-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GkPe6FwEsDlfq8tL8FiEu7suFLL0JJ5H7wa1KohpQDUiKGwH0OZD4vEjihBhTXag phffYwcP5aL+nbUKyEBv/Q== 0001268699-09-000001.txt : 20091209 0001268699-09-000001.hdr.sgml : 20091209 20091209121530 ACCESSION NUMBER: 0001268699-09-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091122 FILED AS OF DATE: 20091209 DATE AS OF CHANGE: 20091209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP CENTRAL INDEX KEY: 0000896747 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141702188 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 BUSINESS PHONE: 5187588158 MAIL ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOULD MARTIN CENTRAL INDEX KEY: 0001268699 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28666 FILM NUMBER: 091230451 MAIL ADDRESS: STREET 1: 166 HIGH STREET CITY: MULLICA HILL STATE: NJ ZIP: 08062 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-11-22 0 0000896747 AMERICAN BIO MEDICA CORP ABMC 0001268699 GOULD MARTIN C/O ABMC ATTN: MELISSA WATERHOUSE 122 SMITH ROAD KINDERHOOK NY 12106 0 1 0 0 EVP & CSO Non-Statutory Stock Option 2.5 2009-11-22 4 J 0 100000 D 2000-06-30 2009-11-22 Common Shares 100000 260000 D Option grant was originally issued on 11/22/99 and reported on a Form 3 filed in 2003. The expiration date of 11/22/09 was reported on this filing. Option grant expired naturally on 11/22/09. When option grant was initially issued it vested over 4 years with first 25% vesting on 6/30/2000. The closing price of the Company's common shares on the date of the grant (11/22/99) was $1.63. The closing price of the Company's common shares on 11/23/09 (the trading day immediately following the expiration date of 11/22/09) was $0.14. Mr. Gould currently has 5 option grants covering a total of 260,000 common shares of the Company. Each of these 5 grants has been previously reported on the appropriate Section 16(a) filing. Martin R. Gould 2009-12-09 -----END PRIVACY-ENHANCED MESSAGE-----